Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Chicken study sheds light on childhood eye disease
Scientists at the Roslin Institute studied chicken embryos to determine how fusion occurs.

New genes identified that are linked to ocular coloboma

A study of chicken embryos has identified new genes that could be responsible for the development of ocular coloboma in humans.

Ocular coloboma causes part of the eye to be missing at birth, severely affecting the patient’s vision. It accounts for up to 10 per cent of all childhood blindness and cannot be treated.

The disease is the result of errors in tissue fusion, which is essential for the formation of the eye and many other organs of the developing embryo.

Scientists at the Roslin Institute studied chicken embryos to determine how fusion occurs and identified genes that are switched on or off during the process.

One of the many newly identified genes included Netrin-1, which scientists say is likely to be critical in humans and other species, as well as in organs other than the eye.

Lead author Dr Joe Rainger said: “Identifying new genes and processes involved in tissue fusion will improve our understanding of how fusion defects occur, and whether these may be preventable.

"The fusion-genes we have revealed are also an excellent resource to support the identification of genetic defects in patient sequencing programmes.”

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.